Polycythaemia Vera Pv clinical trials

Explore recruiting polycythaemia vera pv clinical trials.

Recruiting polycythaemia vera pv studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Polycythaemia Vera Pv trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

MITHRIDATE: A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, open-label, multicenter phase 3 study to assess the efficacy and safety of GIVinostat versus hydroxyurea IN JAK2V617F-positive high-risk Polycythemia Vera patients: the GIV-IN PV TRIAL

Hungary, Poland, Italy, Spain, Bulgaria, Croatia +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Polycythaemia Vera Pv trials by city

Polycythaemia Vera Pv clinical trials

Recruiting polycythaemia vera pv studies right now

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Efficacy and Safety of Peginterferon in ET and PV.

Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

Also recruiting in Europe

MITHRIDATE: A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

Randomized, open-label, multicenter phase 3 study to assess the efficacy and safety of GIVinostat versus hydroxyurea IN JAK2V617F-positive high-risk Polycythemia Vera patients: the GIV-IN PV TRIAL

Polycythaemia Vera Pv trials by city

Other conditions